Product Information
FELBAMATE 400 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.7124 per EA under NDC 62559073001. Its NADAC has been published 385 times since Feb 13, 2019.
Strength
400 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559073001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FELBAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA202284On Market Since
9/4/2018
Pharmacological Classes
Price Statistics
The NADAC for FELBAMATE 400 MG TABLET has been published 385 times since Feb 13, 2019, and over the history we have for it it has declined 72.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7124 per EA |
|---|---|
| All-time high | $3.2846 (Oct 16, 2019) |
| All-time low | $0.7124 (Jun 17, 2026) |
| 52-week high | $1.0316 |
| 52-week low | $0.7124 |
| Median price | $1.1756 |
| Average price | $1.6437 |
| Largest weekly change | -59.2% (Oct 21, 2020) |
| Weeks tracked | 385 |
| Tracking since | Feb 13, 2019 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FELBAMATE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FELBAMATE 400 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.7124 per EA (NDC 62559073001), effective Jun 24, 2026.
How has the price of FELBAMATE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for FELBAMATE 400 MG TABLET has declined 72.5%. It has been tracked across 385 weekly CMS publications since Feb 13, 2019.
What are the highest and lowest recorded NADAC prices for FELBAMATE 400 MG TABLET?
Since Feb 13, 2019, the NADAC for FELBAMATE 400 MG TABLET has ranged from a low of $0.7124 (Jun 17, 2026) to a high of $3.2846 (Oct 16, 2019), with a median of $1.1756 per EA.
Are there cheaper alternatives to FELBAMATE 400 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as FELBAMATE 400 MG TABLET, but none are currently priced below it.
Who manufactures FELBAMATE 400 MG TABLET?
FELBAMATE 400 MG TABLET (NDC 62559073001) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification